These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8903079)

  • 21. Atypical MR findings in Wilson's disease: pronounced lesions in the dentate nucleus causing tremor.
    Matsuura T; Sasaki H; Tashiro K
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):161. PubMed ID: 9489523
    [No Abstract]   [Full Text] [Related]  

  • 22. Ocular motility and Wilson's disease: a study on 34 patients.
    Ingster-Moati I; Bui Quoc E; Pless M; Djomby R; Orssaud C; Guichard JP; Woimant F
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1199-201. PubMed ID: 17470473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers.
    Westermark K; Tedroff J; Thuomas KA; Hartvig P; Långström B; Andersson Y; Hörnfeldt K; Aquilonius SM
    Mov Disord; 1995 Sep; 10(5):596-603. PubMed ID: 8552111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of neurological Wilson's disease with corpus callosum abnormalities.
    Zhou ZH; Wu YF; Cao J; Hu JY; Han YZ; Hong MF; Wang GQ; Liu SH; Wang XM
    BMC Neurol; 2019 May; 19(1):85. PubMed ID: 31053106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kayser-Fleischer ring in Wilson's disease: a cohort study.
    Fenu M; Liggi M; Demelia E; Sorbello O; Civolani A; Demelia L
    Eur J Intern Med; 2012 Sep; 23(6):e150-6. PubMed ID: 22863441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biochemical bases and therapeutic possibilities of K. Wilson's hepatolenticular degeneration].
    Grau-Veciana JM; Barraquer-Bordas L
    Arch Neurobiol (Madr); 1967; 30(3):251-74. PubMed ID: 4970136
    [No Abstract]   [Full Text] [Related]  

  • 27. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
    Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
    Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
    [No Abstract]   [Full Text] [Related]  

  • 28. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
    Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
    J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wilson's disease: MRI with clinical correlation.
    Magalhaes AC; Caramelli P; Menezes JR; Lo LS; Bacheschi LA; Barbosa ER; Rosemberg LA; Magalhaes A
    Neuroradiology; 1994; 36(2):97-100. PubMed ID: 8183467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axonal sensory motor neuropathy in copper-deficient Wilson's disease.
    Foubert-Samier A; Kazadi A; Rouanet M; Vital A; Lagueny A; Tison F; Meissner W
    Muscle Nerve; 2009 Aug; 40(2):294-6. PubMed ID: 19609919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Magnetic Resonance Imaging Improvement in a Patient with Wilson's Disease Following Treatment with Trientine Hydrochloride and Zinc Acetate].
    Kim Y; Koide R; Kawata A
    Brain Nerve; 2015 May; 67(5):635-8. PubMed ID: 25957210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
    Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wilson's disease presenting with an unusual cough.
    Crone NE; Jinnah HA; Reich SG
    Mov Disord; 2005 Jul; 20(7):891-3. PubMed ID: 15806570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wilson's disease.
    Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
    Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative transcranial sonography in Wilson's disease and healthy controls: Cut-off values and functional correlates.
    Tribl GG; Trindade MC; Almeida KJ; Alves RC; de Andrade DC; Fonoff ET; Machado AA; Teixeira MJ; Barbosa ER; Bor-Seng-Shu E
    J Neurol Sci; 2018 Feb; 385():69-74. PubMed ID: 29406916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wilson's disease with cognitive impairment and without extrapyramidal signs: improvement of neuropsychological performance and reduction of MRI abnormalities with trientine treatment.
    Chung EJ; Kim EG; Kim SJ; Ji KH; Seo JH
    Neurocase; 2016; 22(1):40-4. PubMed ID: 25988284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features, MRI brain, and MRS abnormalities of drug-naïve neurologic Wilson's disease.
    Pulai S; Biswas A; Roy A; Guin DS; Pandit A; Gangopadhyay G; Ghorai PK; Sarkhel S; Senapati AK
    Neurol India; 2014; 62(2):153-8. PubMed ID: 24823724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment of presymptomatic Wilson's disease.
    Walshe JM
    Lancet; 1988 Aug; 2(8608):435-7. PubMed ID: 2900362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [High field magnetic resonance imaging in Wilson's disease].
    Hitoshi S; Nangaku M; Shimada H; Yamada H; Yoshikawa H; Iwata M
    Rinsho Shinkeigaku; 1990 Feb; 30(2):139-45. PubMed ID: 2350924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.